Rosenberg SA - Search Results

1

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP. Bronte V, et al. Among authors: rosenberg sa. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3183-8. doi: 10.1073/pnas.94.7.3183. Proc Natl Acad Sci U S A. 1997. PMID: 9096367 Free PMC article.

2

Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL.

Irvine KR, McCabe BJ, Rosenberg SA, Restifo NP. Irvine KR, et al. Among authors: rosenberg sa. J Immunol. 1995 May 1;154(9):4651-7. J Immunol. 1995. PMID: 7722317 Free PMC article.

3

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: rosenberg sa. J Immunol. 1995 May 1;154(9):4685-92. J Immunol. 1995. PMID: 7722321 Free PMC article.

4

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.

Bronte V, Tsung K, Rao JB, Chen PW, Wang M, Rosenberg SA, Restifo NP. Bronte V, et al. Among authors: rosenberg sa. J Immunol. 1995 May 15;154(10):5282-92. J Immunol. 1995. PMID: 7730632 Free PMC article.

5

Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen.

Chen PW, Wang M, Bronte V, Zhai Y, Rosenberg SA, Restifo NP. Chen PW, et al. Among authors: rosenberg sa. J Immunol. 1996 Jan 1;156(1):224-31. J Immunol. 1996. PMID: 8598466 Free PMC article.

6

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

Irvine KR, Rao JB, Rosenberg SA, Restifo NP. Irvine KR, et al. Among authors: rosenberg sa. J Immunol. 1996 Jan 1;156(1):238-45. J Immunol. 1996. PMID: 8598468 Free PMC article.

7

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP. Rao JB, et al. Among authors: rosenberg sa. J Immunol. 1996 May 1;156(9):3357-65. J Immunol. 1996. PMID: 8617961 Free PMC article.

8

Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.

Chamberlain RS, Carroll MW, Bronte V, Hwu P, Warren S, Yang JC, Nishimura M, Moss B, Rosenberg SA, Restifo NP. Chamberlain RS, et al. Among authors: rosenberg sa. Cancer Res. 1996 Jun 15;56(12):2832-6. Cancer Res. 1996. PMID: 8665522 Free PMC article.

9

Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.

Wang M, Chen PW, Bronte V, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: rosenberg sa. J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):139-46. doi: 10.1097/00002371-199510000-00001. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8770769 Free PMC article.

10

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.

Carroll MW, Overwijk WW, Chamberlain RS, Rosenberg SA, Moss B, Restifo NP. Carroll MW, et al. Among authors: rosenberg sa. Vaccine. 1997 Mar;15(4):387-94. doi: 10.1016/s0264-410x(96)00195-8. Vaccine. 1997. PMID: 9141209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters